HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SRTS

Sensus Healthcare, Inc. (NASDAQ)

Healthcare — Medical Devices

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

None 4 analysts
$3.03
+$0.01 (+0.33%)
Target: $5.75 (89.8%)
Sign in to add SRTS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$49.72M
P/E Ratio (TTM)-
Forward P/E-181.16
EPS (TTM)$-0.47
Dividend Yield-
Profit Margin-34.50%
Revenue Growth-59.30%
ROE-15.77%
Debt/Equity0.90
Recommendation None
Analyst Target$5.75
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)63.6
Beta1.09
SMA 20-
SMA 40-
52-Week High$5.92
52-Week Low$2.66
50-Day Avg$3.27
200-Day Avg$3.83
Avg Volume61.6K
Volume2.0K

Performance Analysis

NEUTRAL

SRTS presents a mixed picture with both positive and negative indicators.

~ Trading at 11% of its 52-week range.
+ RSI at 63.6 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 59.3% year-over-year.
- Operating at a loss with -34.5% margin.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $5.75 implies 89.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:32 UTC

Back to Screener Export Report